93 research outputs found

    Canonical momentum based numerical schemes for hybrid plasma models with kinetic ions and massless electrons

    Full text link
    We study the canonical momentum based discretizations of a hybrid model with kinetic ions and mass-less electrons. Two equivalent formulations of the hybrid model are presented, in which the vector potentials are in different gauges and the distribution functions depend on canonical momentum (not velocity). Particle-in-cell methods are used for the distribution functions, and the vector potentials are discretized by the finite element methods in the framework of finite element exterior calculus. Splitting methods are used for the time discretizations. It is illustrated that the second formulation is numerically superior and the schemes constructed based on the anti-symmetric bracket proposed have better conservation properties, although the filters can be used to improve the schemes of the first formulation.Comment: 24 pages, 8 figure

    Study on a High-Accuracy Real-Time Algorithm to Estimate SOC of Multiple Battery Cells Simultaneously

    Get PDF
    In traditional battery equalization strategy, open-circuit voltage (OCV) of battery cells was used to judge the difference of SOC between them. However, OCV is not only determined by SOC but also influenced by internal resistance, polarization voltage, capacity, and other nonlinear factors. As a result, OCV is not an ideal indicator of SOC differences, especially in transient conditions. In order to control battery consistency accurately, it is best to use SOC directly as standard for battery consistency judgment and control. To achieve this, an algorithm that can estimate SOC of multiple battery cells simultaneously with low computational complexity and high accuracy is needed. Limited by computing speed of Battery Control Unit (BCU), existing SOC estimation method is hard to estimate SOC of each battery cell simultaneously with high accuracy. In this research, a new SOC estimation strategy was proposed to estimate SOC of multiple battery cells simultaneously for battery equalization control. Battery model is established based on experimental data, and a processor-in-the-loop test system was established to verify the actual performance of the proposed algorithm. Results of simulation and test indicate that the proposed algorithm can estimate SOC of multiple battery cells simultaneously and achieved good real-time performance and high accuracy

    Progress and perspectives of perioperative immunotherapy in non-small cell lung cancer

    Get PDF
    Lung cancer is one of the leading causes of cancer-related death. Lung cancer mortality has decreased over the past decade, which is partly attributed to improved treatments. Curative surgery for patients with early-stage lung cancer is the standard of care, but not all surgical treatments have a good prognosis. Adjuvant and neoadjuvant chemotherapy are used to improve the prognosis of patients with resectable lung cancer. Immunotherapy, an epoch-defining treatment, has improved curative effects, prognosis, and tolerability compared with traditional and ordinary cytotoxic chemotherapy, providing new hope for patients with non-small cell lung cancer (NSCLC). Immunotherapy-related clinical trials have reported encouraging clinical outcomes in their exploration of different types of perioperative immunotherapy, from neoadjuvant immune checkpoint inhibitor (ICI) monotherapy, neoadjuvant immune-combination therapy (chemoimmunotherapy, immunotherapy plus antiangiogenic therapy, immunotherapy plus radiotherapy, or concurrent chemoradiotherapy), adjuvant immunotherapy, and neoadjuvant combined adjuvant immunotherapy. Phase 3 studies such as IMpower 010 and CheckMate 816 reported survival benefits of perioperative immunotherapy for operable patients. This review summarizes up-to-date clinical studies and analyzes the efficiency and feasibility of different neoadjuvant therapies and biomarkers to identify optimal types of perioperative immunotherapy for NSCLC

    Superconductivity above 70 K observed in lutetium polyhydrides

    Full text link
    The binary polyhydrides of heavy rare earth lutetium that shares a similar valence electron configuration to lanthanum have been experimentally discovered to be superconductive. The lutetium polyhydrides were successfully synthesized at high pressure and high temperature conditions using a diamond anvil cell in combinations with the in-situ high pressure laser heating technique. The resistance measurements as a function of temperature were performed at the same pressure of synthesis in order to study the transitions of superconductivity (SC). The superconducting transition with a maximum onset temperature (Tc) 71 K was observed at pressure of 218 GPa in the experiments. The Tc decreased to 65 K when pressure was at 181 GPa. From the evolution of SC at applied magnetic fields, the upper critical field at zero temperature {\mu}0Hc2(0) was obtained to be ~36 Tesla. The in-situ high pressure X-ray diffraction experiments imply that the high Tc SC should arise from the Lu4H23 phase with Pm-3n symmetry that forms a new type of hydrogen cage framework different from those reported for previous light rare earth polyhydride superconductors

    Metabolomics in the Development and Progression of Dementia: A Systematic Review

    Get PDF
    Dementia has become a major global public health challenge with a heavy economic burden. It is urgently necessary to understand dementia pathogenesis and to identify biomarkers predicting risk of dementia in the preclinical stage for prevention, monitoring, and treatment. Metabolomics provides a novel approach for the identification of biomarkers of dementia. This systematic review aimed to examine and summarize recent retrospective cohort human studies assessing circulating metabolite markers, detected using high-throughput metabolomics, in the context of disease progression to dementia, including incident mild cognitive impairment, all-cause dementia, and cognitive decline. We systematically searched the PubMed, Embase, and Cochrane databases for retrospective cohort human studies assessing associations between blood (plasma or serum) metabolomics profile and cognitive decline and risk of dementia from inception through October 15, 2018. We identified 16 studies reporting circulating metabolites and risk of dementia, and six regarding cognitive performance change. Concentrations of several blood metabolites, including lipids (higher phosphatidylcholines, sphingomyelins, and lysophophatidylcholine, and lower docosahexaenoic acid and high-density lipoprotein subfractions), amino acids (lower branched-chain amino acids, creatinine, and taurine, and higher glutamate, glutamine, and anthranilic acid), and steroids were associated with cognitive decline and the incidence or progression of dementia. Circulating metabolites appear to be associated with the risk of dementia. Metabolomics could be a promising tool in dementia biomarker discovery. However, standardization and consensus guidelines for study design and analytical techniques require future development
    corecore